Home / News / FET’s success continues in melt spinning for biomedical

FET's success continues in melt spinning for biomedical

20 Jul '20

2 min read

Pic: FET

Fibre Extrusion Technology (FET), a UK-based supplier of state of the art process technology and equipment for the man-made yarns and fibre extrusion industry, has announced that the company has cemented its position as a world-leading supplier of melt spinning systems for biomedical applications with a further 5 systems scheduled for delivery in 2020.

FET has a long tradition in the biomedical sector, designing and supplying a range of melt spinning systems for the production of precursor materials in medical device applications. FET has a world leading reputation for melt spinning medial grade polymers in both synthetic resorbable and non-absorbable polymers.

“This expertise has provided strong commercial successes for FET. In 2019 the company delivered 4 melt spinning systems for multifilament and monofilament applications and also one turn-key synthetic resorbable suture plant. Due for delivery in 2020 are a further 4 orders, including a multi-functional system that can produce both multifilament and monofilament pre-cursor fibres. The market for this equipment is truly global with customers based in China, SE Asia, Europe and North America,” Richard Slack, managing director at FET, said in a press release.

The in-house process development laboratory has enabled the optimisation of its biomedical melt spinning technology, while ongoing collaboration with biomaterial polymer suppliers has further enhanced the company’s position.

Worldwide demand for melt spinning systems has of course skyrocketed in recent months as this process is widely used for non-woven fibre production for medical grade masks and the FET Laboratory has been running at capacity to accommodate associated client tests and trials.

Fibre2Fashion News Desk (JL)